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Abstract
The tendency for mycobacteria to aggregate poses a challenge for their use in microplate based assays. Good dispersions
have been difficult to achieve in high-throughput screening (HTS) assays used in the search for novel antibacterial drugs to
treat tuberculosis and other related diseases. Here we describe a method using filtration to overcome the problem of
variability resulting from aggregation of mycobacteria. This method consistently yielded higher reproducibility and lower
variability than conventional methods, such as settling under gravity and vortexing.
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Introduction
Tuberculosis (TB) is causing a global pandemic. Approximately
2 billion people are infected and nearly 9 million develop active
disease each year [1]. India bears the heaviest burden, as 40% of
the population is infected [1–5]. Since resistance of TB to existing
drugs is becoming a serious problem, new therapies are urgently
needed [6].
Traditional assays and models for screening anti-Mycobacterium
tuberculosis compounds are lengthy and not well adapted to HTS
[7]. Despite this, Ananthan, et al. [8] have successfully screened
over 100,000 compounds for activity against M. tuberculosis in a
384-well plate assay, using gravitational settling of the supernatant
to reduce variability.
Recently, the faster growing and safer relative of M. tuberculosis,
M. smegmatis, was used to assay several thousand compounds [9].
The success of this effort led to the discovery and approval of
bedaquiline, the first novel anti-TB compound in forty years [3].
Therefore, it is not surprising that as part of the search for new
medicines, libraries of compounds are being screened with high-
throughput methods for activity against M. tuberculosis and
surrogate mycobacteria [10]. In addition to the successful
discovery of bedaquiline, whole cell screens with mycobacteria
have resulted in the nitroimidazole clinical trial candidates PA-824
[11] and OPQ-67683 (Delamanid), [12]and the diamine candi-
date SQ-109 [13] However, the tendency for mycobacteria to
aggregate makes it difficult to distribute equal number of cells in
each well of a microplate, leading to increased assay variability and
lower probability of uncovering potential screening hits unless the
cultures are manipulated to disaggregate the cells.
The hydrophobic and waxy mycolic acid layer in the cell wall is
the cause of aggregation in mycobacteria [14,15]. Without
dispersing the bacteria to single cells, it is difficult to achieve
accurate cell counts and equal distribution into microplate wells.
Dispersants such as Tween 80 or Tyloxapol are commonly added
to the culture media, and this partially mitigates bacterial
‘clumping ’[16]. Mechanical methods of disaggregation include
repeated vortexing [17], sonication [10], needle dispersion [18],
and gravitational settling of larger particles to form a supernatant
[8]. Our attempts to use these mechanical methods in high
throughput were not satisfactory. Either significant amounts of
bacteria were lost, or the methods were overly cumbersome, time
consuming, and only moderately effective.
Besides chemical and physical dissociation of the bacteria to
single cells, others have used metabolic processes to enumerate
Mycobacteria, such as incorporation of 14C palmitate [19] and the
reduction of Alamar Blue (resazurin) [20]. These procedures have
been validated by correlating their signals to the gold standard of
counting colony-forming units (CFUs) on an agar plate. However,
if the CFUs were derived from clumpy cultures, the correlation
with the accurate radiometric or the fluorometric methods may be
poor. Recently, some have suggested PCR as a way to enumerate
the bacteria, but this method does not adequately differentiate
between dead and living cells [21].
In this paper, we describe a method wherein a syringe fitted
with a 5-mm filter is used to easily and rapidly disperse the clumps
of M. smegmatis to a uniform, single-cell culture. This preparation
provided high yields of homogenous single-cell suspensions in a
matter of minutes. We then used a resazurin-resorufin microtiter
plate assay method to quantify live bacteria in the sample. Filtering
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greatly reduced assay variability and, when applied to a high-
throughput screen, was reproducible and precise.
Materials and Methods
M. smegmatis strain mc2155 was obtained from ATCC. The
bacteria were inoculated into Middlebrook 7H9 broth (BD Difco
#271310) with 0.5% glycerol (Fisher Scientific BP229-4), 0.2%
glucose (Sigma-Aldrich G8270), and 0.1% Tyloxapol (Sigma-
Aldrich T8761). Frozen stocks from the same culture were used to
reduce variability. Glycerol (15%) was added to cultures of M.
smegmatis to reach an optical density at 600 nm (OD600 = 1) of one.
Aliquots of 1-ml cultures were stored frozen at 280uC. As needed,
a working solution of bacteria was made by adding 4 mls of 7H9
(supplemented as above) to 1 ml of a frozen stock. This working
solution was also used for enumerating CFU of M. smegmatis on
plates of 7H9 with agar (Fisher A360). To filter the cultures, 5-mm
pore filters (Millipore SLSVO25LS) were used. The bacteria
working solution was drawn into a syringe and expelled through
the filter. Bac Titer-Glo, a cell viability reagent that measures
intracellular ATP concentration, was obtained from Promega
(G8230).
To assess our methodology of dissociating clumps, bacteria were
either untreated, vortexed for three minutes at the highest setting,
or filtered as described above. Cells were then diluted to 2.26105
CFU/ml and 45 ml added to each well of 384-well black assay
plates with clear bottoms (Corning #3712) using a MultiDrop
Combi (Thermo Fisher 5840400). Lids were attached and the
plates were sealed in a zip-lock bag and placed into a 37uC
incubator. Following a 24 or 48-hour incubation, 5 ml of 0.025%
resazurin (Sigma-Aldrich, R7017) was added to each well. After 3–
4 hours of incubation at 37uC, the fluorescence was measured by
excitation at 530 nm and emission at 590 nm using a fluorimeter
(EnSpire Alpha, Perkin Elmer). No major differences were
Figure 1. Comparison of unfiltered and filtered M. smegmatis. Unfiltered M. smegmatis under 40x magnification (A) and plated onto agar (B);
M. smegmatis filtered through 5-mm pore filter under 40 x magnification (C) and plated onto agar (D), scale bar applies to both A and C.
doi:10.1371/journal.pone.0096348.g001
Table 1. Recovery of M. smegmatis after Vortexing and Filtration.
Unfiltered Vortexed Filtered
OD at 600 nM 0.34260.010 0.31760.009 0.11960.004
Bac Titer-Glo 220,000610,243 224,00068,539 189,00065,066
CFU per 0.0007 ml 38.75618.26 61.0632.99 47.7569.29
Mean 6Standard Deviation; n = 4.
doi:10.1371/journal.pone.0096348.t001
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observed between 24 and 48-hour incubation, therefore, as a more
expedient method, we chose the overnight incubation procedure.
To perform HTS, compounds were dispensed using a NanoScreen
liquid handler (NanoScreen NSX 15360). The robot transferred
5 ml of 10 mMcompounds from 384-well compound plates
(Greiner Bio One, 781280-1B) into 384-well Corning black assay
plates, mentioned above. The Library of Pharmacologically Active
Compounds (LOPAC), obtained from Sigma-Aldrich (LO1280),
was used to validate this protocol.
M. tuberculosis H37Rv was grown in 5 ml 7H9 broth supple-
mented with 0.5% glycerol, 0.5% bovine serum albumin, 0.2%
dextrose, 0.85% NaCl, and 0.05% Tyloxapol for 3 days at 37uC.
Two ml of culture was removed and syringe-filtered through a 5-
mm pore filter. An equal volume of 10% formalin was added to
both the filtered and unfiltered bacteria and incubated at room
temperature for one hour before removal from the BSL3 for
microscopy using a Leica DMIRB Inverted Fluorescence/DIC
Microscope with Photometric HQ2 camera.
Figure 2. Histogram of unfiltered, vortexed and filtered M.
smegmatis. Distributions of resorufin fluorescence signals from 384
wells of a 384-well plate contained unfiltered (A), vortexed (B) or filtered
(C) M. smegmatis. After the treatment, the bacteria were distributed into
the 384-well plates followed by the addition of resazurin, which was
converted to resorufin by the living bacteria.
doi:10.1371/journal.pone.0096348.g002
Figure 3. Agreement analysis of duplicate plates from unfil-
tered, vortexed and filtered bacteria. Correlation of two duplicate
assay plates tested against LOPAC compounds using unfiltered bacteria
(A), vortexed bacteria (B) and filtered bacteria (C).
doi:10.1371/journal.pone.0096348.g003
Filtration of Mycobacteria
PLOS ONE | www.plosone.org 3 May 2014 | Volume 9 | Issue 5 | e96348
Results and Discussion
We first used light microscopy to study the propensity of
mycobacteria in culture to form clumps of thousands of individual
organisms. These clumps are readily detected, as seen in Figure 1A.
The aggregates vary widely in size, with large ones approaching
100 mm in diameter. When the M. smegmatis cultures were plated
in the CFU-assay, colonies of different sizes were evident (Fig.1B),
most likely as a result of different sized clumps of bacteria forming
the colony. That is, a large colony came from a large clump of
bacteria while a smaller clump formed a smaller colony. The lack
of homogeneity in mycobacteria cultures made it difficult to obtain
accurate and consistent CFU counts. To dissociate the clumps to
achieve homogeneity in the culture, we vortexed the culture for
3 minutes at maximum speed; but the clumps remained in the
culture (data not shown). Filtration, on the other hand, readily
eliminated the clumps, leaving behind a uniform culture of single
bacteria about 3–5 mm long (Fig. 1C). When the filtered cultures
were plated, the resulting colonies were uniform in size (Fig. 1D).
One drawback of other methods currently used to produce
single-cell suspensions of Mycobacterium spp. is the loss of a
significant fraction of the cells. This problem is particularly severe
with the gravitational settling method [8]. After settling at 1 g for 1
hour, a mostly single-cell suspension is obtained by utilizing the
upper half of the culture, but at the cost of a loss of 70% of the cells
in the culture. At first it appeared that our filtration method also
resulted in a significant loss of cells. The filtered cultures had an
OD600 of about one-third of the unfiltered sample, OD600 = 0.119
and OD600 = 0.342 respectively (Table 1) suggesting that 66% of
bacteria had been lost during filtration. However, when we either
measured the ATP level in the culture with a luminescence assay,
or enumerated the bacteria by plating them on agar, we did not
observe this loss (Table 1). We believe that the OD readings
decrease because OD600 is dependent on light-scattering, not
absorbance [22–24]. Light is scattered as the sixth power of the
radius of a particle, so the larger particles in the unfiltered cultures
were disproportionately represented in the OD600 signal [25],
artificially increasing the signal.
Our high throughput screening strategy employs cultures in
384-well plates incubated with resazurin to assess viability
[18,26,27]. To precisely measure inhibition in the presence of
compounds, we need to ensure that equal numbers of cells are
dispensed into each well. We compared the repeatability of
dispensing either unfiltered, vortexed, or filtered cultures. Histo-
grams of these data revealed that samples of the unfiltered cultures
were highly variable, with a broad ‘tail’ of many wells having large
fluorescence and a non-normal, bi-modal distribution with a
coefficient of variation (CV) greater than 28%, (Fig 2A). Samples
from cultures that had been vortexed were less variable, with a
peak of fluorescence at about 200,000 units, but the distribution
was still non-normal and bi-modal with a CV greater than 22%
(Fig 2B). In contrast, samples from filtered cultures were normally
distributed with a CV of about 7% (Fig 2C). These differences
were observed in five separate experiments.
To test if filtration improved the performance of HTS of
compounds against M. smegmatis, we performed replicate assays of
a diverse set of compounds and compared the results [28]. We
dispensed populations of unfiltered and filtered bacteria into
duplicate 384-well plates that contained compounds from the
LOPAC library. A pivot plot of the percent inhibition in the first
replicate plate compared to the inhibition in the second plate is
shown for the unfiltered (Fig. 3A), vortexed (Fig. 3B) and filtered
(Fig. 3C) bacteria. The correlation between the replicate assays is
excellent with the filtered cultures, indicating that the assay is
repeatable. The Z’ score [29] calculated from the results with
filtered cells is greater than 0.9 while unfiltered and vortexed
cultures have values of 0.35 and 0.62 respectively. The high Z’
values with filtered cultures (Fig. 3C) indicate that this method will
give better HTS data than unfiltered and vortexed cultures that
have lower Z’ values and higher standard deviations (Fig. 3A and
3B). Compared to untreated cultures, vortexing did improve the Z’
and the standard deviation, but not as much as filtering the
cultures.
When this simple filtration method was extended to M.
tuberculosis, we observed similar results, i.e. single cells were
produced from clumps in this species as well (Fig. 4A and 4B).
Therefore this technique for the production of single cells from
aggregates is not limited to the model species M. smegmatis.
Figure 4. Micrograph of unfiltered and filtered M. tuberculosis. Unfiltered M. tuberculosis under 40x magnification (A) and filtered through 5-
mm pore filter under 40x magnification (B), scale bar applies to both A and B.
doi:10.1371/journal.pone.0096348.g004
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Filtration does not appear to impact the growth or metabolism
of the mycobacteria because filtered and unfiltered bacteria have
similar growth rates and ATP levels. In any case, the filtered
cultures reform clumps within a few hours (data not shown). This
method meets the criteria required for quality data from HTS
[28,30], and has quickly become our standard technique. We used
log-phase cultures in our screen of the LOPAC library to provide
greater sensitivity to compound inhibition. It is possible that a
different hit profile would emerge if the cultures were allowed to
reach stationary phase prior to the addition of test compounds, but
filtered cultures would still be desirable in this situation, since most
of the variability in plated based assay occurs at the time that the
cells are dispensed into the wells. Besides filtering bacteria in
different growth phases, we have also filtered M. smegmatis cultured
in media with succinate as the sole carbon source. We observed
the same degree of aggregation with the succinate media (data not
shown), and after filtration we again obtained single-cell suspen-
sions. We recommend that this filtration procedure be incorpo-
rated into any protocol where mycobacteria are assayed in a
microplate format.
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